The history of SMA research and therapy development is traced, the three approved treatments are critically compared, and key unresolved challenges including treatment-switching criteria, management of late-diagnosed patients, and the emerging role of biomarkers such as neurofilament light chain and compound muscle act...
Jiayi Liu, Yang Liu, An-Nie Yuan et al.· Frontiers in Human Neuroscie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.